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Background/aim: The mechanism of edema formation in nephrotic syndrome is still poorly understood. We aimed to evaluate the
volume status in children with steroid-sensitive nephrotic syndrome (SSNS) and to emphasize the importance of echocardiography in
demonstrating of volume changes.
Materials and methods: Thirty-two SSNS patients and 30 healthy children were enrolled in this study. The volume statuses of patients
were evaluated by clinical and laboratory features, including fractional sodium excretion (FENa) and distal sodium/potassium exchange
(UK/UNa+K ratio). Inferior vena cava collapsibility index (IVCCI), left atrial diameter (LAD), aortic diameter (AD), and left ventricular
mass index (LVMI) were measured using conventional echocardiographic methods.
Results: FENa was lower in children with NS; however, the distal K/Na ratio of the patient and control groups did not differ. In addition,
IVCCI, LAD, AD, and LVMI were not different among groups. When evaluating the volume status of patients, 8 patients (25%)
were hypovolemic while 24 patients (75%) were nonhypovolemic (normovolemic or hypervolemic). LAD was significantly lower in
hypovolemic patients.
Conclusion: The majority of children with SSNS are normovolemic or hypervolemic and echocardiography is an easy and valuable
method for the evaluation of volume status in these patients.
Key words: Children, edema, inferior vena cava collapsibility index, left atrial diameter, nephrotic syndrome, sodium

1. Introduction
Nephrotic syndrome (NS) is a common type of renal disease
in childhood. The disease is characterized by massive
proteinuria, hypoalbuminemia, and edema. Edema is one
of the cardinal features of NS, but its pathogenesis is still
not entirely understood (1,2).
By definition, edematous nephrotic patients always
have a total body excess of both sodium and water. Edema
in NS is usually considered to be due to massive proteinuria,
which leads to hypoalbuminemia and retention of sodium
and water to compensate for intravascular volume
depletion (1–3).
Although patients with nephrotic syndrome have
increased total body water and sodium, the intravascular
volume status of these patients is somewhat controversial.
Two hypotheses have been proposed to explain the
intravascular situation in the nephrotic syndrome:
the underfill hypothesis and overfill hypothesis (2–5).
Assessment of intravascular volume in patients is routinely
demonstrated by clinical and biochemical data. However,
* Correspondence: drcivilibal@hotmail.com
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these data alone are not sufficient for the assessment
of blood volume. In addition, vasoactive hormones,
renal function tests, and lithium clearances can be used
to evaluate the intravascular volume. In recent years,
tests that can be performed more quickly and easily are
recommended. Examples of these tests are fractional
sodium excretion (FENa) and urinary sodium/potassium
exchange (UK/UNa+K ratio) (1). The purpose of this study
is to evaluate the intravascular volume status in children
with steroid-sensitive nephrotic syndrome (SSNS)
and to determine the value of the echocardiographic
measurements in assessment of the volume changes.
2. Materials and methods
2.1. Patients and study design
The patients were diagnosed with the presence of edema,
massive proteinuria (>40 mg m–2 h–1 or a urine protein/
creatinine ratio of >2.0 mg/mg), and hypoalbuminemia
(<2.5 g/dL), with normal serum creatinine and
urea levels and without macroscopic hematuria and
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hypocomplementemia. Patients who were in remission in
response to corticosteroid treatment alone were defined as
SSNS patients.
This was a cross-sectional study of children with newonset NS. The study began with 33 patients. The patient’s
weight, height, blood pressure, and pulse rate were
measured on admission day. The initial treatment was
started as 60 mg m–2 day–1 (2 mg kg–1 day–1) of prednisone
for 4 to 8 weeks. After the urine had become protein free,
it was followed by 40 mg/m2 every other day for 4 to 8
weeks and then a gradual taper until it was discontinued.
One patient who did not achieve remission following
the standard regimen of 4-week daily prednisone was
excluded from the study. None of the patients had been
administered steroids or immunosuppressive drugs
during the previous 3 months. We evaluated the patient’s
volume status by clinical and laboratory features (levels
of blood urea, FENa, and UK/UNa+K ratio). Thirty age- and
sex-matched healthy children served as the control group.
This study was approved by the local research ethics
committee (28.05.2009/41). Informed consent was
obtained from the parents of all subjects. Our study
conformed to good medical and laboratory practices and
the Declaration of Helsinki on Biomedical Research.
2.2. Laboratory measurements
Blood samples were obtained in the morning before
breakfast. Total protein, albumin, blood urea nitrogen,
creatinine, sodium, potassium, cholesterol, triglyceride,
and complements (C3 and C4) and in spot urine sodium,
potassium, and creatinine were measured at the same
time. Although the random urine protein/creatinine ratio
correlates highly with daily urinary protein loss, 24-h
urine samples were collected for determination of urinary
protein excretion in our study.
Serum and urinary concentrations of sodium,
potassium, urea nitrogen, and creatinine were measured
by standard biochemical methods using an Architect
C1600 clinical analyzer (Abbott, Saint-Laurent, Quebec,
Canada). Urinary sodium and potassium excretion levels
were measured by a potentiometric method and creatinine
in urine was analyzed with flame photometry.
Fractional sodium excretion (FENa, %) was calculated
by following the standard formula: (Urinary Na × Plasma
Cr)/(Urinary Cr × Plasma Na) × 100. The quotient of distal
K-Na was taken as an indicator for sodium/potassium
exchange in the distal tubule. This quotient was calculated
using the following formula: distal K-Na= (UK/UNa+K) ×
100.
2.3. Echocardiographic examination
Echocardiographic examinations were done by the same
pediatric cardiologist to determine the volume load of
all patients after the patient had taken a 10-min rest. All
of the measurements were performed at least 3 times.

Inferior vena cava (IVC) diameter during expiration and
maximal inspiration was measured from 1 to 2 cm under
the diaphragm with color Doppler echocardiography.
The IVC collapsibility index (IVCCI) was measured by
the following formula: [(maximal diameter of IVC on
expiration – minimal diameter on inspiration)/(maximal
diameter on expiration)] × 100 (6).
Left atrium diameter (LAD) at the parasternal
position was measured. LAD was determined as diameter
of left atrium (mm)/body surface area (m2). Aortic
annulus diameter (AD) was measured independently
from the two-dimensional parasternal long axis view
(7). Left ventricular mass (LVM) was calculated using
measurements made according to the recommendations
of the American Society of Echocardiography (CAC1 12):
LVM = 0.8{1.04([LVEDD + PWT + IVSDT]3 – [LVEDD]3)}
+ 0.6 g, where LVEDD is left ventricular diameter in end
diastole, PWT is posterior wall thickness in diastole,
and IVSDT is interventricular septum thickness in end
diastole. The calculated mass correlates well with necropsy
values for LVM (8). Left ventricular mass index (LVMI)
was calculated as LVM divided by height (m)2.7. Correcting
LVM for height2.7 minimizes the effect of sex, race, age, and
obesity (9). A routine echocardiographic examination was
also performed to diagnose other cardiac pathologies.
2.4. Statistical analyses
The analysis was performed using the SPSS for Windows
15.0 (SPSS Inc., Chicago, IL, USA). Data were expressed
as means ± standard deviations or medians, depending on
the distribution. Student’s t-tests, Mann–Whitney U-tests,
and chi-squared tests were used for comparison between
patients and controls. Correlations were assessed using
Spearman’s correlations matrix. Stepwise linear regression
analysis was performed to assess the independent
predictors of urinary sodium and potassium changes.
P-values of less than 0.05 were accepted as statistically
significant.
3. Results
Thirty-two children with newly diagnosed SSNS were
included in this study. The patients were admitted to our
clinic in 1–4 days (median: 2 days) after the onset of edema.
The demographic characteristics of the study groups are
summarized in Table 1. Average weight at presentation
(actual weight) was 9% higher than the posttreatment
(dry) weight (respectively, 32.36 ± 20.18 kg vs. 29.21 ±
19.22 kg).
Serum urea, creatinine, sodium, potassium, and
complements of the patients were normal and there
was no statistically significant difference among patient
and control groups (P > 0.05). As expected, serum total
protein and albumin were lower while total cholesterol
and triglyceride were higher in children with SSNS. Urine
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Table 1. Comparison of demographic characteristics of the study groups.
Patients (n = 32)

Controls (n = 30)

P

Age (years)

7.78 ± 5.17

9.47 ± 4.17

>0.05

Sex (M/F)

24/8

23/7

>0.05

Height (cm)

120.9 ± 29.2

129.6 ± 23.0

>0.05

Weight (kg)

32.36 ± 20.18*

28.81 ± 14.07

>0.05

*Mean posttreatment (dry) weight was 29.21 ± 19.22 kg.

sodium and potassium concentrations were lower in
patients than controls (Table 2). In addition, FENa was
significantly lower in patients with SSNS, but the mean
distal K-Na was similar in both groups (Table 3).
When the echocardiographic indices of nephrotic
and healthy children were compared not regarding
volume status, there was no difference between the two
groups (Table 4). We did not detect a correlation between
echocardiographic parameters and urine indicators (FENa
and distal K-Na).
Afterwards, NS patients were divided into two groups
as hypovolemic and nonhypovolemic according to their
clinical and laboratory characteristics. Tachycardia,

dizziness, orthostatic hypotension, muscular cramps,
and delayed capillary refill were considered as clinical
signs of hypovolemia. Accompanied by clinical signs of
hypovolemia, the patients with FENa levels below 1%
and/or distal tubular K/Na ratios above 60% were defined
as hypovolemic [1]. Based on this definition, 8 (25%) of
32 patients with nephrotic syndrome were hypovolemic,
while 24 (75%) of them were nonhypovolemic
(normovolemic or hypervolemic). Pulse rates were higher
and systolic and diastolic blood pressures were lower in
hypovolemic patients than nonhypovolemic patients
(Table 5). In the hypovolemic group, there was dizziness
in 3 patients and muscle cramps in 2 patients. One

Table 2. Biochemical parameters of study groups.
Patients (n = 32)

Controls (n = 30)

P

Urea (mg/dL)

24.6 ± 9.8

24.2 ± 7.3

>0.05

Creatinine (mg/dL)

0.46 ± 0.15

0.53 ± 0.08

>0.05

Sodium (mmol/L)

137.2 ± 3.92

137.7 ± 2.09

>0.05

Potassium (mmol/L)

4.26 ± 0.38

4.23 ± 0.38

>0.05

Total protein (g/dL)

4.06 ± 0.53

7.21 ± 0.39

<0.001

Albumin (g/dL)

1.92 ± 0.62

4.37 ± 0.42

<0.001

Total cholesterol (mg/dL)

359 ± 156

154 ± 18

<0.001

Triglyceride (mg/dL)

272 ± 239

126 ± 71

0.001

Complement-3 (g/L)

128 ± 26

122 ± 47

>0.05

Complement-4 (g/L)

22.5 ± 5.3

21.9 ± 5.5

>0.05

Spot urine Na (mmol/L)

59.4 ± 59.3

155.3 ± 58.3

<0.001

Spot urine K (mmol/L)

35.2 ± 27.6

83.6 ± 37.5

0.001

Table 3. Renal tubular sodium and potassium excretion.
Patients (n = 32)

Controls (n = 30)

P

FENa (%)

0.84 ± 0.25

1.25 ± 0.29

0.001

Distal K-Na (%)

42 ± 23

36 ± 17

>0.05

FENa, Fractional sodium excretion; Distal K-Na, sodium/potassium exchange in the distal tubule.
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Table 4. Echocardiographic parameters of the intravascular volume.
Patients (n = 32)

Controls (n = 30)

P

LVMI (g/m )

40.33 ± 15.95

38.25 ± 8.37

>0.05

AD (mm)

21.54 ± 4.76

20.82 ± 4.31

>0.05

LAD (mm/m2)

27.7 ± 8.45

22.96 ± 7.37

>0.05

IVCCI (%)

14.32 ± 5.89

11.26 ± 3.76

>0.05

2

LVMI, Left ventricular mass index; AD, aortic diameter; LAD, left atrium diameter; IVCCI, inferior
vena cava collapsibility index.
Table 5. Pulse rates, blood pressures, and echocardiographic findings according to volume status in
SSNS patients.
Hypovolemic (n = 8)

Nonhypovolemic (n = 24)

P

Pulse rate (/s)

93.67 ± 6.66

81.09 ± 4.41

0.012

SBP (mmHg)

80.7 ± 5.1

97.6 ± 9.9

0.005

DBP (mmHg)

46.7 ± 4.5

62.7 ± 6.1

0.025

LVMI (g/m2)

36.92 ± 8.61

41.26 ± 17.65

>0.05

26.53 ± 5.92

20.17 ± 3.60

>0.05

LAD (mm/m )

23.01 ± 12.69

28.98 ± 7,23

0.03

IVCCI (%)

12.35 ± 8.55

14.85 ± 5.38

>0.05

AD (mm)
2

SBP, Systolic blood pressure; DBP, diastolic blood pressure, LVMI, left ventricular mass index; AD,
aortic diameter; LAD, left atrium diameter; IVCCI, inferior vena cava collapsibility index.

patient’s capillary refill time was prolonged (>2 s). When
comparing echocardiographic parameters of patients
with and without hypovolemia, the mean LAD values of
hypovolemic patients were significantly lower than the
values of nonhypovolemic patients. LVMI, AD, and IVCCI
values were similar in both groups (Table 5).
4. Discussion
NS is a disease characterized by massive urinary protein
losses, resulting in hypoalbuminemia and edema
formation (1–4). This prospective study was planned to
evaluate the volume status using clinical and laboratory
methods in children with SSNS.
The balance between capillary hydrostatic pressure
and capillary oncotic pressure prevents edema formation
in healthy subjects. The status of intravascular volume
in patients with nephrotic syndrome is somewhat
controversial. Two hypotheses, he underfill and
overfill hypotheses, have been suggested to explain the
intravascular state in nephrotic syndrome (1,2,5). Underfill
hypothesis refers to the reduced effective circulating blood

volume, while overfill hypothesis indicates the expanded
intravascular volume (4,5,10,11).
Detection of intravascular volume is very important
for a patient’s therapeutic management in NS. Clinical
symptoms alone are often unreliable for an assessment
of blood volume. For this purpose, vasoactive hormones,
renal function tests, and lithium clearances can be used.
However, these tests are relatively expensive and timeconsuming. The measurements of FENa and UK/UNa+K
ratio correlate well with plasma aldosterone levels and
provide useful tests for detecting hypovolemia (1–4).
Therefore, we evaluated the intravascular volume state
of nephrotic patients by measurements of FENa and UK/
UNa+K in addition to their clinical findings.
In this study, FENa was significantly lower in patients
than that of the control group. However, there was no
statistically significant difference among patient and
control groups regarding distal K-Na (UK/UNa+K), which is
an indicator for sodium/potassium exchange in the distal
tubule. The results were similar to those of Donmez et
al. (12) and Gurgoze et al. (13), whereby severe sodium
retention was described in children with edematous NS.
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The notion of sodium reabsorption related to the RAA
system activated by hypovolemia in cases of edematous NS
is easier to explain. However, determination of probable
intrarenal sodium reabsorption in nonhypovolemic
patients is a more critical issue. In our study, the important
contribution of sodium reabsorption to the formation
of edema has been demonstrated in accordance with
the results of previous studies. Sodium reabsorption, a
contributor to the formation of edema, is accomplished
in renal tubules. It mostly occurs in the proximal renal
tubule. Many studies demonstrating proximal tubular
sodium reabsorption in the formation of edema are
available (12–15).
In patients with NS, urinary potassium-sodium
exchange rate (UK/UNa+K ratio) is investigated in order to
demonstrate the role of sodium reabsorption of the distal
tubule on the pathogenesis of edema (16,17). In our study,
FENa was lower in NS patients than controls, while mean
distal K-Na was similar to that of controls. In other words,
no significant difference in distal tubular potassiumsodium exchange parameter was found. Based on this, we
concluded that the distal tubules did not have a significant
impact on sodium reabsorption. Our results confirmed
the studies that demonstrated the importance of sodium
reabsorption in proximal tubuli for the development of
edema. Gurgoze et al. (13) identified intrarenal sodium
reabsorption in the pathogenesis of edema in NS. Vande
Welle et al. (14) detected that the rate of distal tubular
potassium-sodium exchange is markedly higher in favor
of sodium retention in cases of hypovolemic NS, while
in nonhypovolemic patients they did not detect such a
significant impact of the distal tubule, in accordance with
our results. They also suggested that the main determinant
of sodium reabsorption is the proximal tubule, as in
previous studies. In the early phase of NS, urinary indices
reveal an overlap of primary and secondary sodium
retention (18). FENa alone cannot be used to differentiate
between primary and secondary sodium retention.
However, in children with NS, strong positive correlations
were found between UK/UNa+K ratio and plasma aldosterone
(19). It can be useful in differentiating primary sodium
retention from secondary sodium retention in NS patients
(18).
Our patients were divided into two groups as
hypovolemic and nonhypovolemic according to the
above-mentioned clinical and laboratory criteria. Kapur
et al. (20) defined as hypovolemic the patients who had
FENa of <1%. However, in phase 2 of their study, the
FENa criterion for the volume status was modified and
patients with FENa of <0.2% were identified with volume
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contraction. We thus have not decided on the basis of
urine indicators alone. According to these definitions, we
identified that the majority of children with SSNS (75%)
were nonhypovolemic.
Plasma rennin activity, vasoactive hormones like
aldosterone, and ANP are indirect indicators of the
circulating volume. The concept of sodium reabsorption
associated with the RAA system, which is activated with
hypovolemia in edematous cases of SSNS, can be explained
more readily (13). The most important limitation of our
study is that these indicators have not been investigated.
The second aim of our study was to determine the
value of echocardiographic measurements (LAD, IVCCI,
LVMI, and AD) on volume changes. For the estimation
of circulating blood volume, IVCCI and LAD have been
reported as valuable predictive factors. Decreased IVCCI
and/or increased LAD indicate the increased volemic
status in patients (12,13,21,22). Increased LVMI is defined
as an increase in the mass of the left ventricle, which can be
secondary to an increase in wall thickness, an increase in
cavity size, or both. This increase in mass predominantly
results from a chronic increase in the afterload of the left
ventricle caused by hypertension and/or by chronic volume
load (23–25). Aortic annulus diameter enlargement has
been reported in children with hypertension other than
Turner and Marfan syndromes (26,27). However, neither
LVMI nor AD has been studied in children with NS to
date.
Donmez et al. (12) reported that the IVCCI of
edematous NS patients was significantly lower and LAD
values were not different from the controls. The study by
Gurgoze et al. (13) did not include a control group, and NS
subgroups were compared among themselves. They found
no difference between groups in terms of both the IVCCI
and LAD. In our study, echocardiographic measurements
of our patients did not differ from controls.
We reevaluated the echocardiographic parameters
of patients after separating them into two groups
according to volume status. LAD measurements of
hypovolemic patients were found to be significantly
lower than in nonhypovolemic patients (P = 0.03). Other
echocardiographic findings were similar between these
two groups in our study (Table 5).
In conclusion, the majority of children with SSNS are
normovolemic or hypervolemic rather than hypovolemic.
LAD is the best echocardiographic parameter that shows
the volume status of these patients. Lastly, we suggest
that there is a weak impact of the distal tubule on sodium
reabsorption, because distal K-Na exchange of nephrotic
patients is not different from that of healthy children.
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